ANTIVIRAL CELLULAR THERAPY FOR ENHANCING T-CELL RECONSTITUTION BEFORE OR AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (ACES) PBMTC SUP1701
What is the goal of the study?
The primary objective of this phase I/II study is to determine the feasibility, safety, and antiviral efficacy of administering partially HLA-matched VSTs to mediate antiviral activity in HSCT recipients with persistent viral reactivations or infections of CMV, EBV or adenovirus
Who can participate in the study?
Please contact the study team listed below to learn more.